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Recent evidence showed that microRNA-7 (miR-7) played an important role in the pathol-
ogies of lung-related diseases. However, the potential role of miR-7 in acute lung injury 
(ALI) still remains poorly understood. Here, we assessed the effect of miR-7 deficiency 
on the pathology of ALI. We, first, found that the expression of miR-7 was upregulated in 
lung tissue in murine LPS-induced ALI model. Notably, we generated miR-7 knock down 
mice by using miRNA-Sponge technique and found that miR-7 deficiency could amelio-
rate the pathologies of lung as evidenced by accelerated body weight recovery, reduced 
level of bronchoalveolar lavage (BAL) proinflammatory cytokines and decreased number 
of BAL cells in ALI mice. Moreover, the proportion and number of various immune cells 
in BAL, including innate immune cell F4/80+ macrophages, γδT cells, NK1.1+ T cells, 
and CD11c+DCs, as well as adaptive immune cell CD4+ T cells and CD8+ T cells, also 
significantly changed, respectively. Mechanistic evidence showed that KLF4, a target 
molecule of miR-7, was upregulated in lung tissues in ALI model, accompanied by 
altered transduction of NF-κB, AKT, and ERK pathway. These data provided a previously 
unknown role of miR-7 in pathology of ALI, which could ultimately aid the understanding 
of development of ALI and the development of new therapeutic strategies against clinical 
inflammatory lung diseases.
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inTrODUcTiOn
The development of acute lung injury (ALI), a clinically important complication of severe ALI 
in humans is a complex process, including a series of integrated steps, including the infiltration 
of innate and adaptive immune cells and the conversion in the balance of proinflammatory and 
anti-inflammatory cytokines (1–4). Recent evidence showed that microRNAs (miRNAs), small 
endogenous RNAs of 21–25 nucleotides capable of guiding the post-transcriptional silencing of 
their target mRNAs through base pairing encompassing mature mRNA 3′UTR (5, 6), played an 
important regulatory role in the development of ALI (7, 8). For example, Li et al. (9) reported that 
cardiopulmonary bypass-induced ALI could lead to dynamic changes in miRNA expression in lungs, 
including miR-21, miR-127, miR-145, and miR-204. Xu et al. (10) found that miR-17 expression was 
downregulated during development of ALI, accompanied by upregulation of its target gene FoxA1, 
and may play an important role in ALI. Our previously study also found that miR-155 ASO treatment 
could enhance the recovery of ALI through C/EBPβ, which was mediated by IL-10-secreting M2-like 
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macrophages (Mφ) induced expansion of Tregs (11). These stud-
ies indicated that miRNAs might be a potential candidate for the 
therapy against ALI. Therefore, further study on the possible role 
of distinct miRNA molecules in the development of ALI could 
not only benefit the understanding of pathology of ALI but also 
be valuable for the development of novel clinical therapeutic 
strategies.
MiR-7 was a distinct miRNA family member and played an 
important role in the context of health, especially in organ differ-
entiation and development (12, 13). Recent studies showed that 
miR-7 was involved in the development of various mammalian 
diseases, including lung-related diseases (14, 15). To lung cancer, 
accumulating evidence suggested that miR-7 was an important 
regulator in the development of lung cancer through controlling 
the growth and invasion, as well as apoptosis, of lung cancer 
cells and was emerged as a novel potential therapeutic target in 
lung cancer. Similarly, our new evidence also showed that miR-7 
could regulate the proliferation and metastasis of lung cancer 
cells in vitro and in vivo (16). Moreover, the reduced expression 
of miR-7 was associated with the sites mutation of its promoter 
region in lung cancer tissues (17). However, the potential role of 
miR-7 in other lung-related diseases remains largely unknown. 
Interestingly, Akbas et al. (18) reported that the level of miR-7 was 
increased and might be a potential biomarker in chronic obstruc-
tive pulmonary disease. Moreover, Buggele et al. (19) found that 
influenza A virus infection could induce the expression of miR-7 
in human respiratory cells, indicating miR-7 may be involved 
in the antivirus inflammatory reaction. Therefore, these studies 
raised a question regarding whether miR-7 also was involved in 
the development of lung-related inflammatory diseases, includ-
ing ALI, which remains to be fully elucidated.
To address this aim, we generated miR-7 knock down (KD) 
mice by using miRNAs-Sponge technique and found that miR-7 
deficiency could obviously attenuate the pathologies of lung in 
LPS-induced ALI mice model, which related to altered expres-
sion of related cytokines and infiltration of innate and adaptive 
immune cells. Of note, KLF4, a target molecule of miR-7, was 
upregulated in lung tissues, accompanied with reduced expres-
sion of NF-κB and phosphorylation of AKT and ERK. Thus, it is 
the first study showed that miR-7 played an important role in the 
pathology of ALI, closely correlated with upregulated expression 
of KLF4, which could ultimately aid the understanding of devel-
opment of ALI and the development of new therapeutic strategies 
against clinical inflammatory lung diseases.
MaTerials anD MeThODs
generation of mir-7 Knock Down Mice
We annealed and ligated, gel purified and cloned oligonucleotides 
for miR-7 binding sites with 5-nt spacers (one spacer: 5′-CGCG-
3′) for 6 bulged sites (one bulged site: 5′-AACAAAATCGAGG- 
-TCTTCCA-3′), into pEGFP-C2 vector (Invitrogen) digested 
with HindIII and KpnI enzyme for the construction of pEGFP-
C2-miR-7 sponge vector.
We next established miR-7 KD (miR-7KD) FVB/N mice 
using pEGFP-C2-miR-7 sponge vector with the help of Cyagen 
Biosciences Inc. To identify miR-7KD mice, we designed the 
primers spanning the EGFP sites and miR-7SP sequence, 
forward (P1): CGCACCATCTTCTTCAAGGA, reverse (P2): 
TGGAAGACCTCGATTTTGTTC. The predicted PCR product 
was 505 bp. All animals were housed under specific pathogen-free 
conditions at Zunyi Medical College. And all animal experiments 
were performed according to the guidelines for the Care and Use 
of Laboratory Animals (Ministry of Health, China, 1998). The 
experimental procedures were approved by the ethical guidelines 
of Zunyi Medical College laboratory Animal Care and Use com-
mittee (permit number 2013016).
lPs-induced Murine ali
FVB/N mice (8- to 10-week-old) and miR-7KD mice (8- to 
10-week-old) were challenged with i.p. injection of 10  mg/kg 
LPS (Escherichia coli 0111:B4; Sigma) dissolved in 150 μl PBS. 
Then the body weight of all mice was detected for 10 consecutive 
days. At indicated time point, the bronchoalveolar lavage (BAL) 
sample, lung tissue, or spleen were obtained.
Bronchoalveolar lavage
Immediately after euthanasia and exsanguination, 1.8 ml aliquots 
of PBS were slowly infused in the murine lungs through the 
tracheostomy and then withdrawn gently. Drainage or suction 
of perflubron or exudate in the airway was not performed before 
this lavage. This lavage was repeated four times using the same 
syringe. The collected lavage fluid was stored in a 2-ml tube on 
ice. The fluid was centrifuged at 400 × g and 4°C for 5 min, and 
the cell sediment was washed with PBS. The cell-free supernatant 
was centrifuged again at 16,000 × g and 4°C for 10 min, stored 
at −80°C and used for determination of cytokine content via 
ELISA. To the pellet, contaminating erythrocytes were lysed with 
1 ml 0.15 M NH4Cl solution for 5 min and washed with PBS. 
Next, the pellet was resuspended for analysis.
histopathology
Lung tissue was fixed in 4% paraformaldehyde, embedded in 
paraffin, and cut into 4-μm-thick sections. Sections were stained 
with H&E, and images were taken with Olympus IX-71 micro-
scope. Two investigators blinded to group assignments analyzed 
the samples and determined levels of lung injury. All lung fields 
at original magnification 200×, 100×, and 40× were examined 
for each sample.
Flow cytometry
Surface markers of various immune cells were evaluated by flow 
cytometry (FCM) with Beckman Gallios (Beckman Coulter, Inc.). 
FCM was performed on Beckman Gallios (Beckman Coulter, 
Inc.) with CellQuest Pro software using directly anti-Mouse 
monoclonal conjugated mAbs against the following markers: 
F4/80-Percp-Cy5.5 (clone: BM8; no. 45-4801-82), γδT-APC 
(clone: eBioGL3; no. 17-5711-81), NK1.1-APC (clone: PK136; 
no. 17-5941-81), CD11c-PE (clone: N418; no. 12-0114-82), 
CD86-APC (clone: GL1; no. 17-0862-81) and MHC-II-PE (clone: 
M5/114.15.2; no. 12-5321-81), CD4-Percp-Cy5.5 (clone: GK1.5; 
no. 12-0041-82), CD8-Percp-Cy7 (clone: 53-6.7; no. 25-0081-81), 
CD62L-PE (clone: MEL-14; no. 12-0621-81), CD69-APC (clone: 
H1.2F3; no. 17-0691-82), with corresponding isotype-matched 
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controls (eBioscience). To detect proportion of F4/80+ cells, γδT+ 
cells, NK1.1+ cells, CD11c+ DC cells, CD4+ T cells, and CD8+ 
T cells, as well as functional molecule expression of CD86 and 
MHC-II on F4/80+ cells, and surface molecule expression of 
CD62L and CD69 on CD4+ T cells in BAL and splenocytes, cells 
were stained with these corresponding Abs (1:100), respectively, 
at 4°C for 30 min and washed twice before analysis, according to 
the manufacturer’s protocol.
real-Time Pcr
The conventional primers were obtained from Shanghai Sangon 
Biological Engineering CO., and the TaqMan probes of miR-7 
(000386) and U6 (001793) were purchased from Life Technologies, 
the other reagents were from TAKARA Bio Inc., Reverse tran-
scriptase reactions and real-time PCR assays were performed 
according to the manufacturer’s protocols, all Reverse tran-
scriptase reactions, including no-template controls and Reverse 
transcriptase minus controls, were run in triplicate in BIO-RAD 
CFX96 (Bio-Rad Laboratories). The expression of miR-7 was per-
formed according to the TaqMan assays and samples were normal-
ized by evaluating U6 expression. The other following primers were 
used: IL-6 forward: 5′-GGAAATCGTGGAAATGAG-3′, reverse: 
5′-AGGACTCTGGCTTTGTCT-3′; IL-4 forward: 5′-AACG 
AGGTCACAGGAGAA-3′, reverse: 5′-CCTTGGAAGCCCTAC 
AGA-3′; IFN-γ forward: 5′-TCTGAGACAATGAACGCTAC-3′, 
reverse: 5′-TTCACATCTATGCCACT-3′; KLF4 forward: 
5′-GCCCAACACACACGACTTC-3′, reverse: 5′-GGCAGGA 
AAGGAGGGTAGTT-3′; GAPDH forward: 5′-AGCAGTCCCG 
TACACTGGCAAAC-3′, reverse: 5′-TCTGTGGTGATGTAAA 
TGTCCTCT-3′. Gene expression levels were quantified using 
the BIO-RAD CFX96 detection system (Bio-Rad Laboratories), 
and the samples were normalized by evaluating GAPDH. Relative 
expression was calculated using the comparative threshold cycle 
(Ct) method.
elisa
The BAL level of TNF-α, IL-1β, IL-6, TGF-β, IL-10, as well as 
IL-4, and serum level of TNF-α, IL-10 were determined using 
Quantikine Immunoassay kits according to the manufacturer’s 
instructions, respectively (eBioscience).
Western Blotting
Western blotting was performed on cytosolic cellular extracts. 
Equal amounts of protein were resolved under reducing condi-
tions on a 10% SDS-polyacrylamide gel. Protein migration was 
assessed using protein standards (Bio-Rad, CA, USA). Transfer 
to a nitrocellulose membrane was performed 60 min at 250 mA 
using a wet transfer system. Equal protein loading was confirmed 
with Ponceau staining. The membrane was washed in 5% skim 
milk in PBS plus 0.05% Tween 20 (PBST) for 2 h to block non-
specific protein-binding sites on the membrane. Immunoblotting 
was performed using an mAb to Rabbit-polyclonal anti-mouse 
KLF4 (Cell Signaling Technology; no. 4038), Rabbit-monoclonal 
anti-mouse NF-κB (Cell Signaling Technology; no. 4764), Rabbit-
polyclonal anti-mouse p-NF-κB (Cell Signaling Technology; 
no. 3039), Rabbit-monoclonal anti-mouse ERK (Cell Signaling 
Technology; no. 4695), Rabbit-polyclonal anti-mouse p-ERK 
(Cell Signaling Technology; no. 4370), Rabbit-monoclonal anti-
mouse AKT (Cell Signaling Technology; no. 4691) or Rabbit-
monoclonal anti-mouse p-AKT (Cell Signaling Technology; no. 
4060), Rabbit-monoclonal anti-mouse β-Actin (Cell Signaling 
Technology; no. 4970) at a dilution of 1/800 in a non-fat milk-Tris 
buffer. The membrane was then washed in PBST and subsequently 
probed with a secondary anti-rabbit Ab-conjugated to HRP (Cell 
Signaling Technology; no. 7074) at a dilution of 1:2000. The 
signal was detected and analyzed using the chemiluminescence 
Imaging System (ChemiScope5600, CLINX, Shanghai, China), 
each experiment was performed in triplicate.
immunohistochemistry
Immunohistochemical staining was performed following 
standard procedures. The formalin-fixed paraffin-embedded 
tissues were sliced into 4-μm-thick sections, deparaffinized, 
and rehydrated. Then, the cells were fixed with 95% ethanol for 
15 min. Antigen retrieval was performed in 10 mmol/L citric acid 
buffer (pH 6.0) for 10 min using a 750 W microwave. Endogenous 
peroxidase activity was blocked with 3% hydrogen peroxide in 
methanol for 15  min. After incubation with rabbit anti-mouse 
KLF4 antibody (1:1000 dilution; CST; no. 3087) and anti-mouse 
NF-κB antibody (1:100 dilution; CST; no. 4764) overnight at 
4°C, the sections were washed in phosphate-buffered saline and 
incubated with a polymer horseradish peroxidase-conjugated 
secondary antibody (ZSGB-Bio, Beijing, China) for 60 min. The 
sections were further incubated with Liquid DAB Large-Volume 
Substrate-Chromogen System (ZSGB-Bio, Beijing, China) and 
counterstained with hematoxylin. The immunostaining was 
evaluated using an Olympus IX-71 light microscope (Olympus, 
Tokyo, Japan).
In Situ hybridization
To evaluate the cellular distribution of miR-7 in the lungs, in situ 
hybridization was performed based as previously described (20) 
with some modifications. Briefly, before hybridization incuba-
tion, all solutions were prepared with diethyl pyrocarbonate-
treated water. After deparaffinization and rehydration, tissue 
sections were treated by proteinase K digestion. After blocking 
with normal goat serum (1:100), sections were next incubated or 
microwave heating and were then incubated with hybridization 
cocktail containing miR-7 probe (1:1000 dilution; EXIQON; no. 
38485-01) at 42°C for 16  h. Then alkaline phosphatase-labeled 
anti-digoxigenin antibody (1:500) (Roche Diagnostics) for 
1  h, and the reaction products were colorized with nitro blue 
tetrazolium/5-bromo-4-choloro-3-indolyl phosphate (NBT/
BCIP) (ZSGB-Bio, Beijing, China), then the tissues were coun-
terstained with Mayer’s hematoxylin and systematically viewed 
under a light microscope (Olympus IX-71).
statistical analyses
The data were analyzed with GraphPad Prism 5.0 and were 
presented as the mean  ±  SD. Student’s t-test was used when 
two conditions were compared, and analysis of variance with 
Bonferroni or Newman–Keuls correction was used for multiple 
comparisons. Probability values of <0.05 were considered signifi-
cant; two-sided tests were performed.
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resUlTs
generation of mir-7 Knock Down Mice
To investigate the potential role of miR-7 in the development of 
ALI, we detected the relative expression level of miR-7 in murine 
12 organs, including heart, lung, brain, kidney, and so on. Data 
showed that miR-7 expression had a higher level in lung tissue 
(Figure S1A in Supplementary Material). Expectedly, we further 
found that the expression of miR-7 significantly increased in 
pathogenic lung tissues in LPS-induced ALI mice (Figure S1B in 
Supplementary Material, p < 0.05). Together, these data indicated 
that miR-7 might be involved in the development of ALI.
Accumulating evidence showed that miRNA Sponge strategy 
was valuable approach for the downregulation of specific miRNA 
expression in vivo (21, 22). Moreover, it is difficult to generate 
miR-7 deficiency mice using traditional strategies, including 
TALENs and CRISPR, because of mature miR-7 molecule is 
transcribed from three different genomic loci on chromosomes 
9, 15 and 19, respectively (23). Then, we used miRNA Sponge 
(miR-SP) strategy to generate mice with miR-7 deficiency. The 
design and proof of principle of miR-SP technology is to con-
struct a eukaryotic expression vector encoding an expression 
cassette for miR-7-SP sequence, the miR-7-SP elements included 
inserting tandemly arrayed miR-7 binding sites into the 3′UTR of 
a reporter gene encoding destabilized EGFP driven by the CMV 
promoter. Binding sites for miR-7 seed family were perfectly 
complementary in the seed region with a bulge at positions 9–12 
to prevent RNA interference-type cleavage and degradation of 
the sponge RNA, the bulge contained six repetitive sequences 
complementary to miR-7 with mismatches for enhanced stabil-
ity (Figure 1A). Then, transgenic mice were generated carrying 
one or two copies of the miR-SP cassette through putting the 
miR-7SP carrier to inject murine fertilized eggs, after which were 
transplanted into the oviduct of pseudo-pregnant mice female, 
and 3 weeks after birth (Figure 1B). To verify a special KD of 
miR-7 in FVB/N mice, we designed primers (P1 and P2) span-
ning the EGFP sites and miR-7SP sequence, and the predicted 
PCR product size was 505 bp. Then, we detected both wild-type 
(WT) mice and miR-7KD mice, while only miR-7KD mice could 
amplify 505  bp specific products (Figure  1C). Importantly, we 
found that the relative expression of miR-7 was obviously reduced 
in lung in miR-7KD mice (Figure 1D, p < 0.05). To confirm these 
data, we further detected the expression of miR-7 in lung tissues 
of miR-7KD mice using in situ hybridization and obtained similar 
results (Figure 1E). Consistently, the relative expression of miR-7 
in other various organs and tissues in miR-7KD mice also 
decreased significantly (Figure S2 in Supplementary Material, 
p < 0.05). These results demonstrated that miR-7KD mice were 
successfully generated using miR-SP Technology.
Deficiency of mir-7 ameliorated 
the Pathologies of ali
Next, we observed the possible effects of miR-7 deficiency on the 
development of ALI using a murine model of LPS-induced ALI. 
Results showed that the loss of body weight was attenuated in 
LPS-treated miR-7KD group, compared with that in LPS-treated 
WT group (Figures 2A,B, p < 0.05). Importantly, the morphology 
of lung tissue of mice in LPS-treated miR-7KD group was smaller 
than that in LPS-treated WT group (Figure 2C). Furthermore, the 
weight and the weight index of lung tissue were also significantly 
reduced (Figures 2D,E, p < 0.05). Meanwhile, hematoxylin-eosin 
staining showed that the infiltration of inflammatory cells in lung 
tissue of miR-7KD ALI mice markedly decreased (Figure  2F). 
The cell apoptosis of lung tissue was involved in the pathology 
of lung injury (24, 25). As shown in Figure 2G, real-time PCR 
analysis further showed that the expression of anti-apoptotic pro-
teins BCL-XL in lung tissue increased significantly in LPS-treated 
miR-7KD mice (p < 0.05), even though the expression of p53 did 
not change significantly (p > 0.05). Conversely, the expression of 
pro-apoptotic proteins BAX and BAD were decreased obviously 
(p < 0.05), indicating the cell apoptosis of lung tissue decreased 
in miR-7KD ALI mice.
To confirm this phenomenon, we further detected the level 
of related cytokines in ALI mice. As shown in Figures 2H–J, 
the concentration of proinflammatory factor TNF-α, IL-1β, and 
IFN-γ in BAL in LPS-treated miR-7KD group decreased sig-
nificantly compared with those in the control group on 3 days 
(p < 0.05). By contrast, the concentration of anti-inflammatory 
factor IL-10 and TGF-β increased noticeably (p < 0.05), even 
though the concentration of IL-4 in BAL did not change 
significantly (Figures  2K–M, p >  0.05). To verify these data, 
we detected the relative expression of these cytokines in 
lung tissues, and similar results were obtained (Figure S3 in 
Supplementary Material). Finally, we also detected the serum 
level of cytokines TNF-α and IL-10, respectively. Data showed 
that the serum level of TNF-α decreased in LPS-treated miR-
7KD mice (Figure S4A in Supplementary Material, p < 0.05). 
Conversely, the serum level of IL-10 increased significantly 
(Figure S4B in Supplementary Material, p < 0.05). Combining 
these data demonstrated that miR-7 deficiency could obviously 
ameliorate the pathologies of ALI.
mir-7 Deficiency altered the composition 
of immune cells in Bal of ali Mice
The change of immune cell composition, which was closely 
related to inflammatory responses, plays a pivotal role in the 
pathology of ALI (26, 27). Hence, we examined the total number 
cells in BAL from LPS-treated WT and miR-7KD mice. As shown 
in Figure  3A, the total number of inflammatory cells in BAL 
from miR-7KD ALI mice was significantly decreased (p < 0.05). 
We further analyzed the possible changes on proportion of the 
innate immune cells, including F4/80+ Mφ, γδT cells, NK1.1+ T 
cells, CD11c+ Dendritic cells (DCs) in BAL from miR-7KD ALI 
mice and found that the proportion and the absolute number 
of F4/80+ Mφ and CD11c+ DCs obviously reduced in BAL 
(Figures 3B,C,F,G, p < 0.05). Unexpectedly, the absolute number 
of γδT cells in BAL did not change significantly (Figures 3B,C, 
p >  0.05), even though the proportion of γδT cells increased 
(Figures  3B,C, p <  0.05). Meanwhile, we also investigated the 
possible change on adaptive immune cells CD4+ T cells and CD8+ 
T cells, which also played important roles in the development of 
ALI, in BAL of LPS-treated miR-7KD mice. The results showed 
FigUre 1 | The generation of mir-7 deficiency mice. The sketch map of construction of eukaryotic expression vector encoding miR-7-Sponge (termed as 
p-miR-7-Sp) (a) and generation of miR-7 KD mice (B). (c) The identification of DNA. DNA was derived from wild-type (WT) or miR-7KD mice. And the expected 
product (505 bp size) was amplificated by PCR, respectively. (D) The relative expression of miR-7 in lung derived from WT mice and miR-7KD mice (n = 6) were 
detected by Real-time PCR assay. (e) The expression of miR-7 in lung tissue derived from WT mice and miR-7KD was analyzed by In situ hybridization. 
Representative data of three independent experiments were shown. **p < 0.01.
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that the proportion and the absolute number of CD4+ T cells and 
CD8+ T cells are also obviously reduced in BAL (Figures 3H,I, 
p < 0.05). To confirm this phenomenon, we also observed the total 
number, the proportion, and the absolute number of the innate 
immune cells, including F4/80+ Mφ, γδT cells, NK1.1+ T cells, 
CD11c+ DCs, and adaptive immune cells, including CD4+ T cells 
and CD8+ T cells in the spleen. Expectedly, similar results also 
were obtained (Figures S5A–C,F–I in Supplementary Material).
As known, the expression of the functional membrane mol-
ecules on immune cells was closely related to the pathological 
status of inflammatory diseases (28); hence, the expression of 
CD86 and MHC-II molecule in F4/80+ Mφ were analyzed. FCM 
 FigUre 2 | mir-7 deficiency ameliorated the pathology of ali. FVB/N6 mice (WT, n = 6) and miR-7KD mice (n = 6) were administered with i.p. 10 mg/kg 
LPS, respectively. (a) Schematic representation of the animal study. (B) The change on the body weight of WT and miR-7KD mice at indicated time point was 
observed. (c) FVB/N6 mice (WT, n = 6) and miR-7KD mice (n = 6) were administered with i.p. 10 mg/kg LPS, respectively. After 48 h, the morphology, (D) the 
body weight, and (e) the weight index (tissue weight/body weight), as well as (F) the pathology, of lung tissues were analyzed, respectively. (g) The relative 
expression of BAD, BAX, BCL-XL, and p53 in lung tissue also were analyzed by Real-time PCR assay. (h–M) FVB/N6 mice (WT, n = 6) and miR-7KD mice 
(n = 6) were administered with i.p. 10 mg/kg LPS, respectively. After 48 h, BAL was collected and the level of IFN-γ, IL-1β, TNF-α, IL-4, and IL-10, as well as 
TGF-β, was determined with ELISA, respectively. Representative data of three independent experiments were shown. *p < 0.05, **p < 0.01.
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analysis showed that the proportion and absolute number of 
CD86 positive F4/80+ Mφ obviously reduced. And the absolute 
number of MHC-II positive F4/80+ Mφ also decreased sig-
nificantly in BAL, even though the proportion of cells increased 
(Figures  3D,E). Next, we further analyzed the expression of 
activation molecules CD62L and CD69, respectively, in both 
CD4+ T cells and CD8+ T cells. Data showed that the expression 
of CD62L on CD4+ T cells and CD8+ T cells were significantly 
upregulated (Figures 3J,K, p < 0.05). Conversely, the expression 
of CD69 on CD4+ T cells and CD8+ T cells were significantly 
downregulated (Figures  3J,K, p  <  0.05), indicating reduced 
activation of CD4+ T cells and CD8+ T cells. Consistent with 
above data, the absolute number of these cells were also reduced 
vigorously (Figures 3J,K, p < 0.05). Similarly, we also obtained 
the consistent results in the spleen from LPS-treated miR-7KD 
mice (Figures S5D,E,J,K in Supplementary Material). In sum-
mary, our results demonstrate that miR-7 deficiency could 
significantly affect the composition and function of various 
immune cells in BAL, which was closely related to ameliorated 
pathology of lung in ALI mice.
The expression of KlF4 Was 
Upregulated in lung Tissues in  
lPs-Treated mir-7KD Mice
To elucidate the potential molecular mechanism through which 
miR-7 deficiency affected the pathologies of lung injury, we 
searched for putative targets of miR-7 using computer-aided 
miRNA target prediction program, including TargetScan4, 
miRanda, and PicTar, and found 12 putative miR-7 target genes, 
including Snap23, TAB2, KLF4, Smad5, MAPK4, FSTL-1, Tle-4, 
OGT-1, RAF-1, MAPK8, MAPKAP-1, and PTK2, which also were 
closely associated with inflammation reaction according to previ-
ous literatures (29–34). Then, we detected the expression of these 
12 predicted target genes in the lung tissues derived from LPS-
treated WT mice and miR-7KD mice, respectively. Unexpectedly, 
FigUre 3 | mir-7 deficiency altered the immune cell composition in Bal of mice from ali.  
(Continued)
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FigUre 4 | KlF4 was upregulated in lung tissues in lPs-treated mir-7KD mice. (a) FVB/N6 mice (WT, n = 6) and miR-7KD mice (n = 6) were administered 
with i.p. 10 mg/kg LPS, respectively. After 48 h, the relative expression of the potential target genes of miR-7 in the lung tissue were analyzed by Real-time PCR 
assay. (B) Putative miR-7-binding sites in the 3′UTR of KLF4. (c) FVB/N6 mice (WT, n = 6) were administered with i.p. 10 mg/kg LPS. The relative expression of 
miR-7 and KLF4 were detected by Real-time PCR at indicated time points. (D) FVB/N6 mice (WT, n = 6) and miR-7KD mice (n = 6) were administered with i.p. 
10 mg/kg LPS, respectively. After 48 h, KLF4 expression in lung tissue was analyzed by Western Blot and (e) immunohistochemical staining, respectively (original 
magnification 200×, 400×). Representative data of three independent experiments were shown. *p < 0.05, **p < 0.01.
FVB/N6 mice (WT, n = 6) and miR-7KD mice (n = 6) were administered with i.p. 10 mg/kg LPS, respectively. After 48 h, (a) the total numbers of BAL cells were 
calculated. (B) The proportion of F4/80+ Mφ and γδ+ T cells were analyzed by FCM. The percentage and the absolute number of cells were calculated, respectively 
(c). (D) The expression of CD86 and MHC-II on F4/80+ Mφ were analyzed by FCM. The percentage and the absolute number of cells were calculated, respectively 
(e). (F) The proportion of CD11c+ dendritic cells and NK1.1+ T cells were analyzed by FCM. The percentage and the absolute number of cells were calculated, 
respectively (g). (h) The proportion of CD4+ T cells and CD8+ T cells were analyzed by FCM. The percentage and the absolute number of cells were calculated, 
respectively (i). (J) The expression of CD62L and CD69 on CD4+ T cells were analyzed by FCM. And, the percentage and the absolute number of cells were also 
calculated, respectively. (K) The expression of CD62L and CD69 on CD8+ T cells were analyzed by FCM. And, the percentage and the absolute number of cells 
were also calculated, respectively. Representative data of three independent experiments were shown. *p < 0.05, **p < 0.01.
FigUre 3 | continued
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Real-time PCR assay showed that only one target, KLF4, in all 
predicted target genes of miR-7 was significantly upregulated by 
more than 25-fold in the lung tissue of LPS-treated miR-7KD 
mice compared with LPS-treated WT mice (Figures 4A,B).
Recent studies showed that KLF4, a critical regulator in LPS-
induced inflammatory response (35), was one of targets of miR-7 
(36). Moreover, KLF4 also could promote the expression of anti-
inflammatory cytokines, such as IL-10 (37). Then, to investigate 
the potential connection between miR-7 and KLF4 in lung injury 
in ALI, we further detected the relative expression of miR-7 and 
KLF4 in LPS-treated WT mice at different time points. As shown 
in Figure 4C, the relative expression of miR-7 increased signifi-
cantly on day 1, and reached the peak on day 2, then decreased 
on day 3. Consistently, the relative expression of KLF4 decreased 
obviously in day 2 and increased significantly on day 3. Next, to 
verify the role of KLF4 in the effect of miR-7 deficiency on the 
pathology of ALI, we further detected the protein level of KLF4 
in lung tissues from LPS-treated miR-7KD mice and WT mice. 
As shown in Figure 4D, the level of KLF4 protein in lung tissue 
was increased significantly in LPS-treated miR-7KD mice com-
pared with that in LPS-treated WT mice (p < 0.05). To confirm 
these data, we further observed the location of KLF4 protein in 
the injured lung tissue. As anticipated, we found strong KLF4 
protein staining on lung tissue derived from miR-7KD ALI mice 
compared with WT ALI mice (Figure 4E). Collectively, our data 
indicated that miR-7 deficiency could affect the pathology of 
ALI, which was closely due to the upregulation expression of its 
target KLF4.
FigUre 5 | The signaling pathway change of mir-7 deficiency in ali. FVB/N6 mice (WT, n = 6) and miR-7KD mice (n = 6) were administered with i.p. 10 mg/
kg LPS, respectively. After 48 h, the expression level of ERK, p-ERK, AKT, p-AKT, and p-NF-kB in lung tissue were determined with Western Blot (a) and calculated 
(B). (c) The expression of NF-κB was also detected by the immunohistochemical staining. Representative data of three independent experiments were shown. 
*p < 0.05, **p < 0.01. (D) Schematic representation of the underlying mechanism of miR-7 deficiency on ALI. miR-7 deficiency leads to upregulation of KLF4, which 
could successively alter the transduction of NF-κB, ERK, and AKT signaling pathway and contribute to the ameliorated pathologies of ALI.
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mir-7 Deficiency altered the Transduction 
of related signaling Pathway
The multiple signaling pathways, including AKT, ERK, and so 
on, were also involved in the development process of ALI (38). 
Moreover, KLF4 also was reported to be closely related to the 
transduction of these signaling pathways (39). Thus, to elucidate 
whether miR-7 deficiency resulted in the attenuated patholo-
gies of ALI might be related with these signaling pathway, the 
expression of phosphorylation of AKT and ERK were analyzed 
in lung tissue derived from LPS-treated WT mice or miR-7KD 
mice, respectively. Data showed that there were not any change 
on the expression level of AKT and ERK in between miR-7KD 
ALI mice and WT ALI mice (Figures 5A,B, p > 0.05). However, 
the phosphorylation of AKT and ERK in miR-7KD ALI mice 
decreased significantly, compared with those in WT ALI mice 
(Figures 5A,B, p < 0.05).
Furthermore, we also detected the expression of NF-κB, 
which was critical transcription factor for inflammatory reaction, 
in lung tissue from miR-7KD ALI mice. Data showed that the 
expression of phosphorylation of NF-κB also decreased obviously 
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(Figures  5A,B, p  <  0.05). To confirm this phenomenon, we 
further analyzed the expression of phosphorylation of NF-κB 
in lung tissue using immunohistochemical staining and similar 
result was obtained (Figure 5C). These results suggested that the 
evident effect of miR-7 deficiency on the pathology of ALI was 
closely correlated to the altered transduction of NF-κB and AKT, 
as well as ERK, signaling pathway (Figure 5D).
DiscUssiOn
Up to now, this is the first study to explore the potential 
role of miR-7 in the pathologies of ALI. We, first, observed 
that the expression of miR-7 increased significantly in lung 
tissue in murine LPS-induced ALI model. Furthermore, we 
generated miR-7 deficiency mice by using miR-SP technol-
ogy. Importantly, we found that miR-7 deficiency could 
significantly attenuate the pathologies of ALI, evidenced by 
accelerated body weight recovery, reduced infiltration of BAL 
cells and altered level of related cytokines, which was closely 
correlated to upregulation of KLF4, a target of miR-7, and 
altered transduction of related signaling pathway, including 
NF-κB, AKT, and ERK pathway.
Accumulating evidence suggested that miR-SP, which are 
transcripts that carry several in tandem copies of a sequence 
complementary to the miRNA of interest in their 3′UTRs, was 
a promising approach for loss-of-function strategies of distinct 
miRNA molecule in vivo (40, 41). Giusti et al developed a trans-
genic miRNA sponge mouse for investigation on the biological 
function of miR-9 in dendritic growth and synaptic transmission 
in  vivo (42). Most recently, Zheng et  al. constructed “Sponge” 
transgenic mice against miR-27a expression and found that 
Siglec1 and TRIM27 expression, target molecules of miR-27a, 
were elevated in  vivo in antiviral innate response (43). In the 
current study, we generated miR-7 deficiency mice using miR-
SP technology. Our data showed that the relative expression of 
miR-7 in various organs, including lung, spleen, brain, and so 
on, dramatically decreased, indicating miR-7-SP could effectively 
inhibit the expression of miR-7 in vivo. Importantly, we further 
found that miR-7 deficiency could obviously ameliorate the 
development of LPS-induced ALI, evidenced by prevention of 
body weight loss and reduced weight and pathological change of 
lung tissue. Moreover, our data further showed that, miR-7 not 
only was enriched in a variety of normal tissues, including brain 
and lung tissue, which was consistent with previous literature 
(44–46), but also was upregulated in lung tissue of LPS-induced 
ALI model. Similarly, Akbas et  al. (18) reported that the level 
of miR-7 was increased and might be a potential biomarker in 
chronic obstructive pulmonary disease. These data might reflect 
the important role of miR-7 in the development of lung-related 
diseases, including ALI. Therefore, successive research work 
on the expression of miR-7 in clinical ALI cases, as well as the 
potential effect of miR-7 on other animal ALI models that were 
with distinct traits related to diverse pathological characters of 
clinical ALI, is much valuable for the validation on the role of 
miR-7 in pathology of ALI.
The infiltration of innate immune cells and adaptive immune 
cells, including Mφ, γδ+ T cells, and CD4+ T cells, were closely 
involved in the development process of ALI (47). For example, 
Holub and Lawrence (48) reported that the proportion of Mφ in 
BAL increased significantly and was contributed to the pathol-
ogy of ALI. In our study, we found that the proportion and the 
cell absolute number of not only innate immune cells, such as 
F4/80+ Mφ, but also adaptive immune cells, including CD4+ 
T cells and CD8+ T cells, in BAL also decreased significantly. 
Moreover, similar results also were obtained in splenocytes. 
Notably, we further reported that altered expression of activated 
membrane molecular, including CD86 and MHC-II, on F4/80+ 
Mφ cells in LPS-treated miR-7 KD mice. Meanwhile, CD4+ T 
cells and CD8+ T cells also expressed lower level of CD69 and 
higher level of CD62L, displaying a decreased activation pheno-
type. Similarly, Ying et al. (49) reported that downregulation of 
miR-127 could impair the infiltration and function of Mφ, which 
was contributed to the decreased pathology of ALI. Moreover, 
Brusselle et al. (50) also found that the dysregulation of miRNAs 
could contribute to the pathogenesis of lung-associated inflam-
matory diseases, which were related to the impaired activation 
of CD4+ T cells in ALI. Combining these data suggested that the 
change on infiltration and functional molecule of these immune 
cells are contributed to impaired pathologies of ALI in miR-7 
KD mice. We proposed that two factors might be responsible 
for the change on infiltration of immune cells. First, the altered 
cytokine balance was important for the infiltration of immune 
cells because various cytokines, such as IL-10, TNF-α, and so on, 
could affect the migration of immune cells. Second, the potential 
role of miR-7 in biological function of immune cells, even was 
still unknown, also might be contributed to the altered migra-
tion of immune cells. It is interesting to note that recent research 
works showed the important role of distinct miRNA molecules 
in biological function of immune cells (11, 51). Therefore, our 
current data might provide valuable clues for the related research 
work on the potential function of miR-7 in immune cells, which 
also should be helpful for understanding the role of miR-7 in 
development of ALI.
It is well known that some signaling pathways, such as NF-κB, 
AKT, and ERK pathway, were critical for the development of 
inflammatory response (52–54). And KLF4, as one putative 
target of miR-7, played a critical role in the transduction of 
these signaling pathways, which were involved in the develop-
ment of various diseases (55–59). To ALI, genetic analysis 
suggested that KLF4 was one of the leading candidate genes 
associated with increased susceptibility to ALI (60). And KD 
of KLF4 obviously augmented LPS-induced lung injury (61). 
In the present study, we found that the expression level of 
KLF4 increased in lung tissue in LPS-treated miR-7KD mice. 
Importantly, we further found that the transduction of NF-κB 
and AKT pathway, as well as ERK pathway, decreased obvi-
ously. Moreover, the level of proinflammatory cytokines, such 
as TNF-α, IL-1β, and IL-6, also dramatically decreased, and 
the level of anti-inflammatory cytokines, such as IL-10 and 
TGF-β1, conversely increased. Consistently, one most recent 
research work reported that KLF4 could potentially regulate 
the transduction of NF-κB pathway, which closely related to 
decreased levels of the pro-inflammatory cytokines TNF-α (62). 
Moreover, KLF4 also could bind to IL-10 and TGF-β1 promoter, 
12
Zhao et al. MicroRNA-7 Deficiency Ameliorates AIL
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 389
as a transcriptional regulator, and upregulate the transcriptional 
level of IL-10 and TGF-β1, respectively (37, 63). Therefore, given 
the fact that regulation effect of miR-7 on KLF4 expression, 
these data further highlighted the critical role of miR-7/KLF4 
axis in development of ALI, indicating the potential value of 
this axis in the development of therapeutic strategy against 
inflammatory lung diseases.
Taken together, as shown in Figure  5D, we presumed that 
miR-7 deficiency altered that expression of KLF4, which affected 
the transduction of related signaling pathway, such as NF-κB, 
AKT, and ERK, and successively influence on the infiltration of 
various immune cells and the level of inflammatory cytokines, 
which ultimately ameliorated the pathologies of LPS-induced ALI.
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